Serum cytokine levels in patients with Alzheimer's disease.
AUTOR(ES)
Chao, C C
RESUMO
Alzheimer's disease (AD) has been proposed to be an inflammatory disorder. In a recent study, markedly elevated levels of the anti-inflammatory cytokine transforming growth factor beta (TGF-beta) in the serum and cerebrospinal fluid of patients with advanced AD suggested a potential predictive value of this cytokine in patients with AD. In the present prospective study, we tested the hypothesis that the levels of TGF-beta in serum would be increased in patients with AD and could thereby serve as a diagnostic marker. We found that serum TGF-beta levels but not proinflammatory cytokine levels were significantly (P < 0.05) elevated in patients with AD (n = 22) in comparison with the levels in their healthy spousal controls. Also, serum TGF-beta levels were positively correlated (r = 0.45; P < 0.05) with disease severity. Nevertheless, the elevation in serum TGF-beta levels in patients with Ad was modest, and considerable overlap with the control values suggests that the diagnostic usefulness of this cytokine for AD is limited.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=368282Documentos Relacionados
- Screening patients for Alzheimer's disease.
- ACTH and cortisol secretion in patients with Alzheimer's disease.
- Serum levels of S100B and NSE proteins in Alzheimer’s disease patients
- Identical twins with Alzheimer's disease.
- Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease